Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species
- PMID: 20107088
- PMCID: PMC2849570
- DOI: 10.1128/JCM.01709-09
Microbial etiology of travelers' diarrhea in Mexico, Guatemala, and India: importance of enterotoxigenic Bacteroides fragilis and Arcobacter species
Abstract
This study examined established enteric pathogens, Arcobacter species and enterotoxigenic Bacteroides fragilis (ETBF), in 201 U.S. and European travelers with acute diarrhea acquired in Mexico, Guatemala, and India. Arcobacter butzleri and ETBF were detected in 8% and 7% of diarrhea cases, respectively.
Similar articles
-
Prevalence and characterization of enterotoxigenic Bacteroides fragilis and toxigenic Clostridium difficile in a Taipei emergency department.J Microbiol Immunol Infect. 2017 Feb;50(1):83-89. doi: 10.1016/j.jmii.2014.12.005. Epub 2014 Dec 24. J Microbiol Immunol Infect. 2017. PMID: 25648668
-
Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study.J Clin Microbiol. 1994 Apr;32(4):960-3. doi: 10.1128/jcm.32.4.960-963.1994. J Clin Microbiol. 1994. PMID: 8027350 Free PMC article.
-
Enterotoxigenic Bacteroides fragilis-associated diarrhea in children 0-2 years of age in rural Bangladesh.J Infect Dis. 2005 Apr 15;191(8):1245-52. doi: 10.1086/428947. Epub 2005 Mar 14. J Infect Dis. 2005. PMID: 15776370
-
[Enterotoxigenic Bacteroides fragilis as a factor in diarrhea].Mikrobiyol Bul. 2002 Jan;36(1):99-103. Mikrobiyol Bul. 2002. PMID: 12476774 Review. Turkish.
-
Travelers' diarrhea.Curr Opin Infect Dis. 2010 Oct;23(5):481-7. doi: 10.1097/QCO.0b013e32833dfca5. Curr Opin Infect Dis. 2010. PMID: 20683261 Review.
Cited by
-
The Immunopathogenic Potential of Arcobacter butzleri - Lessons from a Meta-Analysis of Murine Infection Studies.PLoS One. 2016 Jul 20;11(7):e0159685. doi: 10.1371/journal.pone.0159685. eCollection 2016. PLoS One. 2016. PMID: 27438014 Free PMC article.
-
Bacteremia caused by Arcobacter butzleri in an immunocompromised host.J Clin Microbiol. 2015 Apr;53(4):1448-51. doi: 10.1128/JCM.03450-14. Epub 2015 Feb 11. J Clin Microbiol. 2015. PMID: 25673792 Free PMC article.
-
A Review of Guidelines/Guidance from Various Countries Around the World for the Prevention and Management of Travellers' Diarrhoea: A Pharmacist's Perspective.Pharmacy (Basel). 2019 Aug 4;7(3):107. doi: 10.3390/pharmacy7030107. Pharmacy (Basel). 2019. PMID: 31382691 Free PMC article. Review.
-
Bacteria from the Genus Arcobacter Are Abundant in Effluent from Wastewater Treatment Plants.Appl Environ Microbiol. 2020 Apr 17;86(9):e03044-19. doi: 10.1128/AEM.03044-19. Print 2020 Apr 17. Appl Environ Microbiol. 2020. PMID: 32111585 Free PMC article.
-
Prospective evaluation of different faecal preservation media for travellers' diarrhoea diagnostic application with multiplex PCR BioFire FilmArray in resource-limited settings.J Med Microbiol. 2025 Jan;74(1):001954. doi: 10.1099/jmm.0.001954. J Med Microbiol. 2025. PMID: 39887178 Free PMC article.
References
-
- Burnens, A. P., P. Boss, F. Orskov, I. Orskov, U. B. Schaad, F. Muller, R. Heinzle, and J. Nicolet. 1992. Occurrence and phenotypic properties of verotoxin producing Escherichia coli in sporadic cases of gastroenteritis. Eur. J. Clin. Microbiol. Infect. Dis. 11:631-634. - PubMed
-
- DuPont, H. L., C. D. Ericsson, J. J. Mathewson, F. J. de la Cabada, and D. A. Conrad. 1992. Oral aztreonam, a poorly absorbed yet effective therapy for bacterial diarrhea in US travelers to Mexico. JAMA 267:1932-1935. - PubMed
-
- DuPont, H. L., R. Haake, D. N. Taylor, C. D. Ericsson, Z. D. Jiang, P. C. Okhuysen, and R. Steffen. 2007. Rifaximin treatment of pathogen-negative travelers' diarrhea. J. Travel Med. 14:16-19. - PubMed
-
- Dupont, H. L., Z. D. Jiang, J. Belkind-Gerson, P. C. Okhuysen, C. D. Ericsson, S. Ke, D. B. Huang, M. W. Dupont, J. A. Adachi, F. J. De La Cabada, D. N. Taylor, S. Jaini, and F. Martinez Sandoval. 2007. Treatment of travelers' diarrhea: randomized trial comparing rifaximin, rifaximin plus loperamide, and loperamide alone. Clin. Gastroenterol. Hepatol. 5:451-456. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical